Evotec Se Adr (EVO)

Überblick Nachrichten Preisverlauf Warum fällt EVO? Forum Prognose Aktiensplit Dividendenhistorie

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Evotec Se Adr Stock (EVO) Company Profile

Evotec Se Adr

Healthcare (1110)

Nächster Verdiensttermin

Neueste SEC-Einreichungen

EVO's Discussions on Twitter

Compare EVO vs TAK, HLN, TEVA, ZTS, UTHR

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
EVO Evotec Se Adr	2.92	1.08B	890.87M	-115.85M	-104.29M	-0.3261
TAK Takeda Pharmaceutical Co Adr	15.91	51.34B	29.91B	1.30B	3.49B	0.4056
HLN Haleon Plc Adr	9.265	41.15B	14.54B	2.22B	2.58B	0.4871
TEVA Teva Pharmaceutical Industries Ltd Adr	34.72	39.67B	17.53B	1.58B	444.18M	1.3457
ZTS Zoetis Inc	80.67	34.09B	9.51B	2.64B	2.14B	6.0361
UTHR United Therapeutics Corp	568.66	24.13B	3.17B	1.29B	1.01B	27.09

Evotec Se Adr Stock (EVO) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2026-04-15	Fortgesetzt	H.C. Wainwright	Buy
2026-02-03	Eingeleitet	Berenberg	Buy
2025-04-24	Hochstufung	Deutsche Bank	Sell → Hold
2024-10-07	Herabstufung	Jefferies	Buy → Hold
2024-08-08	Herabstufung	Deutsche Bank	Hold → Sell
2024-07-29	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2024-07-11	Herabstufung	Deutsche Bank	Buy → Hold
2024-04-12	Hochstufung	Deutsche Bank	Hold → Buy
2024-01-18	Hochstufung	RBC Capital Mkts	Sector Perform → Outperform
2023-06-23	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2023-06-16	Herabstufung	BofA Securities	Buy → Neutral
2023-06-08	Hochstufung	Citigroup	Neutral → Buy
2023-04-04	Hochstufung	Morgan Stanley	Underweight → Equal-Weight
2022-12-09	Eingeleitet	H.C. Wainwright	Buy
2022-11-16	Herabstufung	Deutsche Bank	Buy → Hold
2022-08-10	Herabstufung	Morgan Stanley	Overweight → Underweight
2022-03-02	Fortgesetzt	Cowen	Outperform
2022-01-07	Fortgesetzt	Citigroup	Neutral

Alle ansehen

Evotec Se Adr Aktie (EVO) Neueste Nachrichten

Finanzdaten der Evotec Se Adr-Aktie (EVO)

Evotec Se Adr (EVO)

Evotec Se Adr Stock (EVO) Company Profile

Compare EVO vs TAK, HLN, TEVA, ZTS, UTHR

Evotec Se Adr Stock (EVO) Upgrades & Downgrades

Evotec Se Adr Aktie (EVO) Neueste Nachrichten

Evotec SE stock (DE0005664809): Steady FY 2025 results amid US expansion - AD HOC NEWS

Evotec AG Earnings Call Balances Pain With Promise - The Globe and Mail

Evotec SE stock (DE0005664809): Drug discovery leader eyes US biotech growth - AD HOC NEWS

Evotec places €116.1 million convertible bonds due 2033 - Investing.com UK

Evotec places €116.1 million convertible bonds due 2033 By Investing.com - Investing.com South Africa

Evotec SE stock (DE0005664809): Recent price gains signal short-term momentum - AD HOC NEWS

Evotec SE stock (DE0005664809): HC Wainwright cuts Q2 earnings outlook - AD HOC NEWS

Boyd Gaming posts downbeat Q1 results, joins Coursera, Evotec and other big stocks moving lower in Friday's pre-market session - MSN

Evotec SE stock (DE0005664809): Q1 2026 results show sharp revenue drop amid restructuring - AD HOC NEWS

Earnings call transcript: Evotec Q1 2026 sees revenue drop amid market challenges - Investing.com Canada

Evotec Q1 2026 slides: revenue drops 22% as transformation accelerates By Investing.com - Investing.com Nigeria

Evotec Q1 2026 slides: revenue drops 22% as transformation accelerates - Investing.com

Earnings call transcript: Evotec Q1 2026 sees revenue drop amid market challenges By Investing.com - Investing.com South Africa

Evotec reports wider quarterly loss, misses revenue expectations By Investing.com - Investing.com Canada

Evotec reports wider quarterly loss, misses revenue expectations - Investing.com

Evotec's Share Price Surges! Summer Rally for Desert Gold? Rheinmetall Shares Heading Toward EUR 2,000? - news.financial

Evotec SE Stock (DE0005664809): Q1 2026 Results Due Today - AD HOC NEWS

Evotec nominates Wolfgang Hofmann to supervisory board By Investing.com - Investing.com Australia

Evotec nominates Wolfgang Hofmann to supervisory board - Investing.com

Boyd Gaming Posts Downbeat Q1 Results, Joins Coursera, Evotec And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Sahm

Evotec names Claire Hinshelwood as CFO, replacing Paul Hitchin By Investing.com - Investing.com Australia

Boyd Gaming Posts Downbeat Q1 Results, Joins Coursera, Evotec And Other Big Stocks Moving Lower In Friday - Benzinga

Evotec names Claire Hinshelwood as CFO, replacing Paul Hitchin - Investing.com

Middle East Conflict Weighs on Markets: Food Supply Chains Become a Key Issue – MustGrow, K+S, Evotec, and BioNTech in the Spotlight - news.financial

Evotec SE stock (DE0005664809): Is its drug discovery platform strong enough for biotech recovery? - AD HOC NEWS

Evotec SE stock (DE0005664809): Is its drug discovery pipeline strong enough to unlock biotech upsid - AD HOC NEWS

Evotec SE stock (DE0005664809): Is its drug discovery platform strong enough to unlock biotech upsid - AD HOC NEWS

Evotec SE stock (DE0005664809): Is its drug discovery partnership model strong enough for steady ups - AD HOC NEWS

Evotec SE stock (DE0005664809): Is its drug discovery partnership model strong enough for biotech re - AD HOC NEWS

Evotec SE stock (DE0005664809): Is its drug discovery model strong enough to unlock biotech upside? - AD HOC NEWS

Evotec appoints Ingrid Müller as chief operating officer By Investing.com - Investing.com South Africa

Evotec SE stock (DE0005664809): Is its drug discovery model strong enough to unlock new upside? - AD HOC NEWS

100% Profit Potential in Sight: Vidac Pharma's Chance to Double vs Bayer and Evotec - news.financial

Evotec Q4 2025 slides: strong finish masks segment headwinds By Investing.com - Investing.com Australia

BofA reiterates Evotec stock Underperform rating on execution concerns - Investing.com

Evotec (NASDAQ: EVO) pivots to asset-light model and boosts 2025 liquidity - Stock Titan

Evotec Q4 2025 slides: strong finish masks segment headwinds - Investing.com

Finanzdaten der Evotec Se Adr-Aktie (EVO)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie EVO